Video Tutorial On How To Use NasoNeb
Video Tutorial On How To Use NeTI FLO Sinus Rinse
SINUS MUCOUS ALLERGY
When it comes to Nasal Symptom Management, you can count on us!
Reduce recurring nasal infections by 60-80% by rinsing directly into the nasal cavity with budesonide! Start Budesonide NOT an antibiotic first! Buy yourself some time while waiting on CULTURE AND SENSITIVITY test to come back! Insured and Uninsured patients welcome. Contact us for more info. I’d like to take a moment to share information regarding topically delivered prescribed medications for non-infective nasal symptom management that are regularly provided by Your Health Pharmacy (“YHP”).
BUDESONIDE 1ML/2ML AMPULES
YHP opened its doors in February 2018 and has served patients within the state of Florida, Arizona, Colorado, Georgia, Massachusetts, Minnesota, Nevada, New York, New Jersey, and Pennsylvania ever since. YHP has exceptional customer service, is available to answer patient/prescriber questions, and is a network provider for numerous private insurance plans, Medicare Part D plans, Medicaid plans, and federal plans.
YHP has received numerous requests from prescribers for corticosteroid, antihistamine, anticholinergic, and mucolytic medications that can be delivered nasally for patients with non-infective nasal issues or medical conditions. Add on Azelastine, acetylcysteine or if you need it and antibiotic right into the nasal cavity! Send us your trainwreck patients! Don’t start another round of antibiotics. Very easy to order for your patients! Just print out a form and fax it over or find us in your EMR and send an Escript!
WE DELIVER DIRECTLY TO YOUR PATIENTS!
YHP embraces simplicity. Treating inflammation in the paranasal sinuses, in the lungs, in the ear, in the mouth, or on the skin could often include the utilization of BUDESONIDE 1.0mg-2ml or Budesonide 0.5mg-2ml Vials. This commercially available steroid, already in a liquid form, could be used as: (a) a stand-alone medication, (b) in concert with other medications in LOXASPERSE for nasal symptom management, or (c) in combination with anti-infective medications in LOXASPERSE where anti-inflammatory medications, such as Budesonide, are also deemed useful and desired.
Featured Ingredient LOXASPERSE!
Patients who might benefit from the topical delivery of such medications could include patients who are currently using: (1) nasally delivered steroids, (2) nasally or orally delivered antihistamines, (3) nasally delivered anticholinergics, (4) nasally or orally delivered mucolytics, (5) orally delivered Montelukast, or (6) irrigation systems to clear out the nasal cavities and remove debris.
LOSS OF TASTE AND SMELL FROM COVID?We have answers for that too!
YHP has also received redundant requests for nasally delivered Theophylline which is anticipated to be useful for patients dealing with anosmia.
Intranasal Theophylline Treatment of Hyposmia and Hypogeusia
Robert I. Henkin, MD, PhD; Michael Schultz, RPh; Laura Minnick-Poppe,PharmD Author Affiliations Article Information Arch Otolaryngol Head Neck Surg. 2012;138(11):1064-1070. doi:10.1001/2013.jamaoto.342
We would love to talk with you about the opportunity to serve the medication needs of your patients dealing with such conditions. If this would be of interest to you, or if you would like to have an in-office presentation regarding our services, please do not hesitate to contact the pharmacy at the above listed number, or you can email me directly at rx@yhpharmacy.com.
NasoNeb | Sinus Therapy System
INTRODUCTION
Budesonide nasal irrigation is used for the management of patients with chronic rhinosinusitis and the therapeutic effectiveness of this treatment has become accepted part of standard care.
The objective of this study was to compare the mass of budesonide delivered to a 3D model via high-flow irrigation versus nasal nebulizer, in order to determine how much medication actually arrives at the disease-specifics nasal sites.
METHODS
A nasal replica model based on an MRI dataset (Guilmette) of a healthy male was segmented horizontally into 3 sections for measurement of regional deposition. This model was then used to determine the deposition amounts for the nasal nebulizer (NasoNed System) and rinse bottle (NeilMed Sinus Rinse) with a budesonide nebule (Pulmicort Nebuamp, 500µg/2mL).
The ampoule was added directly to the nebulizer but was diluted with 240ml of 0.9% saline for the rinse bottle as directed. Each section of the model was washed with 5ml of methional and the mass of budesonide determined by HPLC UV-Vis spectrophotometry.
RESULTS
Budesonide recovery from the 3 model locations (Anterior, Mid-section, Posterior) was significantly higher for the nebulizer (81.4µg, 173.2µg, 39.3µg) compared to the rinse bottle (1.0µg, 2.4µg, 1.1µg).
CONCLUSIONS
The use of nebulizer system offers an alternative therapy for clinicians to deliver a greater and potentially more effective corticosteroid dose to patients who have been unable to achieve relief with other spray devices.
Clinicians should also be aware of the limitations of some commercial nasal irrigation system to reliably deliver medication to its intended site of action inside the nose.